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Agenda Item 8 - Intellectual Property Rights Issues 
1. At ICW91, a "statement of principles" on intellectual property 
rights, biosafety and plant genetic resources was introduced for the Group's 
consideration by Mr. Lukas Brader, Co-Chair of the joint TAG-Center Directors 
Committee on Intellectual Property Rights and Plant Genetic Resources. On 
Nox.cmber 7, 1991, the Secretariat distributed a revisedversion of this statement 
(attached). Although there was substantial agreement on the content, some 
procedural matters were raised about issuing the statement at that time. It was 
agreed that the item would be brought before the Group again at its May 1992 
meeting. 
2. Consultations on IPR andbiotechnology issues have beenheld over the 
last nine months within the CGIAR system. These have included discussions with 
representatives of NARS, NGOs, private companies and other CGIAR collaborators, 
as well as seminars and meetings such as the Biotask/ISNAR seminar in September 
1991 on biotechnology policy. The joint TAC-Center Directors Committee met at 
IBPGR in Jarluary 1992 with representatives of Biotask and produced a draft paper 
entitled "CGIAR DiscussionDocument on Intellectual Property, Biosafety and Plant 
Genetic Resources". This paper was discussed at TAC57 (March 1992) and has been 
subsequently revised and is attached hereto. 
3. The two aforementioned papers serve as background documentation for 
the discussion of Agenda item 8 - Intellectual Property Rights Issues. The Group 
will be asked to decide what further action, if any, is required on this subject. 
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DATE: November 7, 1991 
TO: CGIAR Donors 
FROM: The Secretariat 
Suarrested Principles for a Future CGIAR Policy 
on Intellectual Property Rlqhts 
The Center Directors, TAC, the Secretariat and others in the 
system have been working over the past two years toward analyzing the 
potential effects of intellectual property rights on the CGIAR. ICRISAT 
hosted a workshop on this subject for center representatives in Hyderabad 
earlier this year. It is generally agreed among participants in these efforts 
that the CGIAR develop an overall policy on intellectual property rights,, 
plant genetic resources and biosafety. 
Several discussions were he.ld before International Centers Week 
concerning a proposed policy on intellectual property rights. It was agreed 
that a draft policy encompassing the major points listed above should be 
prepared for discussion at the Mid-Term meeting May 1992 in Turkey, and that 
the leading sectlon of the draft policy should include statements of principle 
that would guide the proposed policy. 
The Directors General prepared a list of principles and presented 
it for consideration by the Group during the final ICW91 business session. 
After considerable discussion it was decided that many delegations would like 
to confer at home before deciding to agree or disagree with the principles 
listed. The statement regarding the non-patenting of genes should not be 
interpreted to mean the CGIAR is prepared to patent other life forms. This 
issue will be given more attention and discussion within a larger audience in 
1992. Therefore, it was decided the Secretariat would send the list of 
principles to members of the Group for consideration. 
Members are asked to send any comments or objections to the CGIAR 
Secretariat by November 19, 1991. The short deadline is to clarify and 
facilitate the CGIAR’s representation at the Convention on Biodiversity for 
the United Nations Conference on Environment and Development (UNCED), which 
will begin the third week of November in Nairobi, Kenya. Thank you for your 
assistance. 
SUGGESTED PRINCIPLES FOR A FUTURE CGIAR POLICY 
ON INTELLECTUAL PROPERTY RIGHTS 
During the past year, the CGIAR System (Consultative Group on 
International Agricultural Research) has been working towards an overall CGIAR 
policy on plant genetic resources, intellectual property rights and biosafety 
with the involvement of the international agricultural research centers 
(IARCS), the CGIAR Technical Advisory Committee (TAC) and the members of the 
CGIAR (through BIOTASK- the CGIAR Task Force on Biotechnology). The CGIAR 
recognizes the need to make new biotechnologies available to developing 
countries to address problems in agriculture and the environment. 
An overall CGIAR policy is currently being finalized. However, 
recognizing that the issues are of considerable and increasing international 
interest and concern, the CGIAR System agreed at its recent meeting in 
Washington, D.C., to release a statement of principle guiding its intent in 
these areas, These principles are: 
. The CGIAR reconfirms that the plant genetic resources 
maintained in the genebanks of the IARCs are held in trust 
for the world community; 
e The CGIAR reconfirms its adherence to the principle of 
unrestricted availability to its plant genetic resources; 
. The CGIAR recognizes both Plant Breeders' Rights and the 
concept of Farmers' Rights, in accor?&nce with the agreed 
interpretation of the International Undertaking.on Plant 
Genetic Resources; 
. The CGIAR considers that naturally occurring genes are 
common property, therefore the IARCs of the CGIAR will not 
seek intellectual property protection of such genes; 
. The IARCS of the CGIAR, in respect of novel biotechnological 
techniques, processes and other inventions developed by them, will 
consider seeking intellectual property protection where necessary 
to ensure access to these technologies by developing country 
partners; 
. The CGIAR does not see the protection of intellectual 
property as a mechanism for securing financial return for 
its own investments in research. If an IARC seeks 
intellectual property protection on an invention, any 
financial returns stemming from the commercialization by 
third parties other than NARS (National Agricultural 
Research Systems) in developing countries, will be used to 
further the conservation and use of genetic resources in 
developing countries; 
c 
. - 
2 
l The IARCs of the CGIAR will continue to follow the existing 
internationally recognized OECD guidelines concerning 
biosafety; 
. The CGIAR acknowledges the intergovernmental negotiations 
underway to establish an International Convention of 
Biodiversity for signature at the United Nations Conference 
on the Environment and Development (UNCED) in Brazil in 
June 1992. The CGIAR and its IARCs will ensure that its 
policy is consistent with the articles of the Convention 
once it is agreed. 
OP/JS(cgi pr) 
From: The Secretariat 
Mid-Term Meetiw. May 18-22. 1992 
Istanbul, Turkev 
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INTELLECTUALPROPERTY 
1. BACKGROUND 
In developing its approach to the changing circumstances caused by the wider recognition of 
intellectual property, the CGIAR will maintain a clear distinction between plant genetic resources and 
research products. In relation to plant genetic resources, the CGIAR has already defined the role of the 
Centres as that of trustees, and stressed that the material is held on the understanding that it will be used 
for the benefit of global research. The CGIAR recognizes that the Centres’ genebank collections carmot 
be considered amongst the Centres’ assets. 
As trustees of international germplasm collections, the Centres have an obligation to manage them 
for the benefit of the world community. This management responsibility includes the maintenance and 
enhancement of the accessions held in trust, their defence against physical destruction, and a guarantee 
of unrestricted access for the benefit of the world community. 
In relation to their research products, the Centres primary responsibility is to ensure that they and 
the developing countries they serve continue to have access to needed products and processes. To do so 
means that they must take appropriate and prudent steps to manage their intellectual property. There 
might well be circumstances in which the Centres would wish to protect their own inventions in order 
to prevent preemptive protection by others, which might restrict the availability of those inventions, 
especially to the developing countries. Because much of today’s advanced technology is subject to 
intellectual property protection, Centres cannot always expect to have free access to it. Consequently, 
they will increasingly have to collaborate with institutions that protect their intellectual property in order 
to obtain the use of new products and processes. 
Application.of the above principles to the formulation of future CGIAR policy would imply that the 
Centres would not seek financial returns from intellectual property protection, and that any financial 
returns that might arise from the application of intellectual property protection would not be used to cover 
the Centres’ operating costs. Rather, any such returns would be used for the direct benefit of developing 
countries, perhaps by placing them in an international fund to be used for the conservation of plant and 
animal genetic resources. If such a policy were to be pursued, details of the administration of such a 
fund would have to be carefully considered. 
Based on these principles, the following paragraphs give the rationale for the likely stance that the 
Centres would adopt in relation to different forms of intellectual property (See Index B for descriptions 
of the various categories of specific products and processes). 
2: GERMPLASM COLLECTIONS 
Germplasm accessions in the Centres’ base and active collections constitute the material held in trust 
by them for the world community. The Centres would not seek patent protection or plant breeders’ rights 
on this material. Further, when the Centres provide this germplasm to organizations other than the 
appropriate government authorities in developing countries, they would do so under material transfer 
agreements, and any national authority which received the material would be asked to follow similar 
procedures in passing it on to other organizations. The purpose of these agreements would be to ensure 
that any useful genes discovered in the material could not be withheld from the country from which the 
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CGIAR DISCUSSION DOCUMENT 
ON INTELLECTUAL, PROPERTY, BIOSAFETY AND PLANT GENETIC- RESOURCES 
INTRODUCTION 
The greatest contributions the CGIAR Centres have made to agriculture in the developing world have 
been associated with their ability to facilitate collaboration among scientists in different countries. They 
have been able to do this largely as a consequence of promoting the principles of free access to scientific 
discoveries and the free interchange of genetic resources. It is the CGIAR’s intention that these basic 
principles should be fully enshrined in its future activities. 
Against this background, the need has arisen to consider appropriate ways in which the CGIAR 
should respond to the increasing prominence in biological research of the concepts of intellectual 
property, which are creating both new opportunities and new concerns. The opportunities relate mainly 
to the possibilities for increased investment in biological research, thereby augmenting and accelerating 
the application to human needs of wide areas of biological science. The concerns relate both to the 
restrictions that intellectual property might impose on the free availability of these benefits to developing 
countries, and to the need to ensure safety in the application of new techniques and the release of new 
products. All these topics are interrelated, especially in those CGIAR activities that involve the use of 
germplasm and its products. 
This discussion document takes a broad look at the implications of intellectual property for the work 
of the CGIAR and the interests of the developing countries. In considering germplasm, it builds on the 
1989 “CGIAR Policy on Plant Genetic Resources” and takes into account the International Undertaking 
on Plant Genetic Resources (see Index A). It is intended as a further step in the continuing consultative 
process within the CGIAR System, and with its clients in developing countries. It sets the framework 
for evolving CGIAR approaches to the ownership of intellectual property, to biosafety and to the work 
it supports on the conservation of plant genetic resources. 
material originated, nor could the Centres be prevented from using-the material, or specific genes derived 
from it, for the benefit of developing countries. 
Accordingly, these agreements would require the users to negotiate with the Centres if the original 
material, essentially derived varieties (as defined by the UPOV Convention of 1991), or genes isolated 
from the material were to be protected and used commercially. In these negotiations, the Centres would 
be primarily cognizant of the need to safeguard the interests of the developing countries, rather than to 
derive financial returns. The intention would not be to inhibit the use of the material in crossing 
programmes for purposes of conventional plant breeding nor, in any way, to restrict the free interchange 
of germplasm. 
3. BREEDING MATERIAL UNDER DEVELOPMENT 
Breeding material under development is defined as that which the Centres have improved through 
breeding. Increasingly, the Centres are moving towards the development of strategic germplasm (i.e. 
advanced lines or populations with potential value for further breeding research), rather than producing 
finished varieties. The Centres would not seek patent or plant breeders’ rights on this material, and 
would supply it freely under a material transfer agreement. 
Under such an agreement, the Centres would provide to public or private sector institutions material 
to be used for further breeding and commercialization. Material suitable for use as finished varieties 
would normally be made available solely to the appropriate government authorities in developing 
countries. Such authorities could either release such varieties themselves, or sub-license them to one or 
several firms in the private sector. The Centre’s agreement with the national authority could take the 
form either of a single agreement or an umbrella agreement covering all aspects of germplasm exchange 
over an extended period of time. This would offer the national authority an opportunity to obtain a 
financiai return, if it so wished, and thus to augment scarce financial resources. The primary purpose, 
however, would be to prevent a private company from imposing, through intellectual property protection, 
restrictions on the future use of that material by the Centre or by other developing countries. 
In the case of industrial countries, the Centres could conceivably allow public or private institutions 
to gain rights to improved germplasm under plant variety protection, provided the rights were gained 
through a transparently fair procedure, and did not restrict future use of the material by the Centre. In 
such cases, any financial returns derived from the licensing agreement would be passed to an international 
fund as described above. 
4. OTHER BIOTECHNOLOGICAL PRODUCTS AND PROCESSES 
Biotechnological products include, among others, transgenic plants sub-cellular components, living 
cell lines, vaccines, diagnostic techniques, genetic maps and research procedures and methodologies. 
These are protected by a number of different intellectual property forms in industrial nations. In order 
to obtain these products, the Centres would sometimes find it necessary to negotiate and participate in 
strategic alliances and to recognize intellectual property rights to the various research products. In these 
negotiations, the Centres would ensure access to the new technologies and products of the research for 
developing countries. 
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Transgenic Plants and Gene Constructs 
The patenting of genes in major industrial nations involves rights over recombinant DNA containing 
the gene sequences, plasmids and vectors containing the sequences, plants transformed by vectors 
containing the sequences and products derived from those plants. The patenting of a gene in this fashion 
does not restrict conventional breeding using plant material in which the gene occurs naturally. 
The CGIAR Centres are already cooperating with laboratories which have been isolating, and are 
sometimes modifying, important genes in order to insert these genes into plants to benefit developing 
countries. Effective negotiation of and participation in such cooperative programmes would exceptionally 
require the Centres to recognize certain patent rights in industrial countries and, in some cases, to pursue 
such patents themselves. As they develop these intellectual property rights, it would not be the intention 
of the Centres to seek any benefit from the exercise of these rights other than to ensure that the most 
beneficial advanced technologies and their products would be made available to developing nations at as 
low a cost as possible. 
Vaccines 
Animal vaccines are typically protected by trade secrecy during the early research phase and by 
patents as the product moves closer to commercialization. There have been instances where it has been 
necessary for a Centre to collaborate with a major pharmaceutical company in order to gain access to new 
techniques and apply these to the control of tropical animal diseases This has resulted, for example, in 
collaboration for the production of a new and improved vaccine against East Coast Fever. In this 
instance, one Centre is seeking patent protection on its invention to allow its collaborators to invest in 
the development of the vaccine for the market. Without such a strategic alliance it would not be possible 
for the new vaccine against East Coast Fever to be made available to many developing countries 
Diagnostic Techniques 
New diagnostic techniques for animal and plant diseases can be protected by trade secrecy and 
patents. Increasingly, both universities and industry are protecting these innovations by trade secrecy. 
The Centres would, however, generally make any new diagnostic techniques they develop available 
without restriction. 
Genetic Maps 
The Centres will need to collaborate extensively with public and private sector institutions to develop 
genetic maps for the species of interest. Although these maps have often been subject to trade secrecy, 
the Centres would encourage their public availability. 
Research Processes 
As a rule, the Centers would publish their results rapidly to prevent any possible patenting of their 
research procedures and processes by others. Only exceptionally would they protect their results through 
patents or trade secrets when this would be essential to ensure availability at lowest cost to developing 
countries. 
5. OTHER PRODUCTS 
For the range of other products that arise from Centres’ activities such as publications, audio-visual 
materials, databases and computer software, protection is normally obtained through copyright and this 
is presently a widely adopted procedure by CGIAR institutions. Machinery and equipment invented by 
the Centres are frequently protected by patents, particularly to avoid misappropriation by others. 
6. SUMMARY OF GUIDING PRINCIPLES 
The CGIAR’s preferred policy would be to publish protectable inventions to maintain them in the 
public domain. Within such a policy framework, the CGIAR Centres would seek intellectual property 
protection only after a specific judgement that such protection would assist in bringing the benefits of 
research to developing nation farmers. 
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BIOSAFETY 
Safety in biological research, in the application of its results, and in the use of its products is broadly 
referred to as “biosafety” . In this context, biosafety relates to those regulatory procedures considered 
essential to safeguard human health and the stability of natural ecosystems. It covers not only biological 
science and technology but also the release of novel organisms, both those introduced from one country 
to another for purposes of biological control, and those produced by genetic engineering. 
It is the policy of the CGIAR and the Centres it supports to adhere to national regulations and codes 
of practice of the countries with which they collaborate. Those CGIAR Centres and their contractors 
conducting biological research will form biosafety committees which will include appropriate 
representation from the host country and which will be responsible for monitoring the safe use of 
biological techniques both in the laboratory and under containment conditions. As regards the subsequent 
field testing and environmental impact assessments of exotic or novel organisms, the Centre and its 
collaborators will adhere to national legislation. 
Where no appropriate legislation exists, the Centre will reach agreement with the government 
concerned on the procedures to be followed, based on international or regional codes of practice. Both 
Centres and national governments will, of necessity, be required to keep abreast of new developments 
in biosafety and risk assessment and the Centres will promote collaborative research to expedite such 
assessments. In the course of this collaborative work, Centres will also promote greater awareness of 
the importance of implementation of appropriate biosafety practices. 
CONSERVATION OF PLANT GENETIC RESOURCES 
1. BACKGROUND 
In addition to their overall importance for agricultural research and development, plant genetic 
resources are being seen increasingly as part of the wider concept of biodiversity. Consequently, CGIAR 
activities on plant genetic resources need to be seen in this wider perspective. The purpose of CGIAR 
support for work on plant genetic resources is to ensure that the diversity of germplasm of global or 
regional importance is safely maintained and made available for use in research and plant improvement 
programmes for the benefit of all people. 
Work on genetic resources supported by the CGIAR has traditionally been dedicated primarily to the 
conservation, ex sine, of crop plants, pastures, vegetables and fruits,. together with their wild and weedy 
relatives. Increasingly, however, attention is being given to trees and shrubs, as well as to the 
complementary nature of ex situ and in situ conservation. (See Indexes C and D). 
In this document the term conservation is used in the broad sense to include collecting, 
characterization, documentation, evaluation, multiplication, storage and distribution. The term “plant 
genetic resources”, is interpreted as including relevant plant species containing characters of immediate 
or potential value. In domesticated plants, as well as in trees and shrubs, the total resource is the 
potential inherent in all the genetic combinations produced in the process of evolution, including: 
wild and weedy species; 
landraces and local varieties; 
common varieties of poal value for plant improvement which are not commercially 
available or presently grown by farmers; 
elite germplasm, including inbred lines, breeder’s lines, sources of resistance to biotic 
and abiotic constraints and other genetically modified forms for use in plant improvement 
programmes; 
genetic stocks for use in or produced by research, including special material with 
genetically stable and useful characters, such as aneuploid and polyploid lines, 
morphological and chemical mutants and biological material from biotechnological and 
other research. 
Conservation of plant genetic resources and associated research are major activities of the CGIAR 
Centres. These activities are carried out in close cooperation with national research systems in the 
developing countries and with other institutions. Through technical advice, training and collaborative 
research, the Centres help to strengthen national capabilities. 
The various elements of CGIAR policy on the conservation of plant genetic resources that require 
reaffirmation and wide recognition are outlined in the following paragraphs. 
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2. TRUSTEESHIP OF PLANT GENETIC RESOURCES 
The plant genetic resources maintained in’ international base and active collections by the CGIAR 
Centres are held in trust for the world research and development communities. It is suggested that the 
CGIAR Centres should bring their base and active collections into the global network under the auspices 
of FAO, as defined in the International Undertaking on Plant Genetic Resources’ 
The CGIAR Centres will supply germplasm from their active collections, along with relevant data, 
to any research and development worker anywhere in the world, provided adequate stocks are held at the 
time the request is received or, if not, after multiplication. It is an established practice of the CGIAR 
Centres to repatriate samples of original accessions to countries and communities where it has become 
necessary to replace material no longer available in the national collections or in farmers’ fields. 
3. STORAGE AND SAFETY OF COLLECTIONS 
The CGIAR Centres consider its their responsibility to store all material they hold in trust under 
internationally accepted conditions. In order to ensure the safety of the collections that the CGIAR 
Centres hold in trust, the base collections are duplicated in at least one other long-term storage facility- 
These duplicate collections will be treated in the same manner as the original base collections. 
4. EXPLORATION AND COLLECTING 
All exploration and collecting activities of CGIAR Centres are carried.out in partnership with national 
programmes. During such missions, internationally accepted guidelines are followed, as well as the 
prevailing national regulations for germplasm collecting. The information gathered will include, to the 
greatest extent possible, traditional knowledge about the accessions. A complete set of both the material 
and the information is made available to the country concerned. 
5. MULTIPLICATION AND REGENERATION 
The process of increasing the quantity of a given germplasm accession available from seed or by 
vegetative means, is an important activity for each collection. It allows sufficient amounts of individual 
accessions to be available for exchange and use, as well as for characterization. The CGIAR Centres, 
in partnership with national programmes, ensure that germplasm is multiplied under conditions that 
minimize genetic drift. 
6. CHARACTERIZATION 
Characterization of germplasm collections is an integral part of the responsibilities of a genebank and 
an important prerequisite for the proper management of collections and the promotion of germplasm use. 
The CGIAR Centres carry out characterization of all the accessions in their collections, using standardized 
descriptor lists, which will continue to be developed and updated taking into account the latest scientific 
developments. 
7. EVALUATION 
Close cooperation among genebank managers, plant breeders and scientists from other disciplines is 
crucial to evaluate genetic material effectively for use in plant improvement programmes. The 
development of international crop genetic resources networks is seen as a major tool to achieve this aim. 
IBPGR and the relevant international commodity centres will play a major role in the development of 
these networks, Resulting evaluation data are made freely available to all users upon request. 
8. DATA MANAGEMENT AND INFORMATION 
The CGIAR Centres promote the development of databases for genebanks as a prerequisite for the 
proper management of plant genetic resources. The CGIAR Centres disseminate this information to users 
and facilitate its exchange between collaborating institutions. They also assist in the management of 
information for the known genepool of the species for which they have accepted such responsibility. 
9. GERMPLASM HEALTH AND PLANT QUARANTINE 
The CGIAR Centres adhere to national quarantine regulations. For germplasm exchange, they apply 
internationally accepted phytosanitary standards, such as those set out in the FAO/IBPGR Technical 
Guidelines for the Safe Movement of Germplasm. The CGIAR Centres will continue to contribute to the 
development of guidelines, improved methods for indexing and treatments for plant health to strengthen 
still further the safe movement of germplasm. 
The CGIAR Centres will routinely adhere to sanitation and testing procedures with the objective of 
progressively building collections free of known pathogens. In addition to the national plant health 
certificate, a standardized CGIAR germplasm health statement will accompany all outgoing germplasm. 
10. RESEARCH AND TRAINING 
The CGIAR Centres support relevant research on genetic resources, both at their own institutions and 
through collaborative projects. They also support workshops and conferences on plant genetic resources, 
as well as the training of germplasm specialists, giving special attention to modem biological techniques. 
11. SUSTAINING AN INTERNATIONAL COMMITMENT 
The long-term conservation of plant genetic resources requires the sustained commitment of all 
concerned. The CGIAR sees itself as an integral component of, and an active participant in, the global 
initiatives on plant genetic resources. The CGIAR accepts the responsibility it has assumed for the 
continued funding of the genebanks at the Centres it supports. 
The CGIAR Cent&s are well placed to assist in strengthening international activities on plant genetic 
resources at the scientific and technical levels. The CGIAR Centres are committed to the allocation of 
appropriate resources to ensure the continued availability of the genetic resources they hold in trust. 
It is the policy of the CGIAR to promote strong linkages between the conservation of plant genetic 
resources and plant improvement programmes. To this end, the CGIAR Centres play a catalytic role 
through such activities as the development of regional and global genetic resources networks. Strong and 
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sustained support for all these activities will be needed if the CGIAR goal of sustainable production of 
food-crops and trees in the developing countries is to become a reality. 
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Index A 
International Undertaking on Plant Genetic Resources 
The CGIAR welcomes the initiatives being taken in the framework of the FAO International 
Undertaking on Plant Genetic Resources. These initiatives recognize the contributions of farmers, rural 
communities, and countries to genetic resources, and acknowledge the need for international financial 
mechanisms to ensure sustainable conservation and utilization of plant genetic resources. 
The basic principles were enunciated in 1983 by the FAO conference which adopted the 
International Undertaking on Plant Genetic Resources (PA0 Resolution 8/83). The International 
Undertaking is a nonbinding legal instrument, the objective of which is to ensure that plant genetic 
resources’ especially species of present or future economic or social importance, are explored, collected, 
preserved, evaluated, and made available for plant breeding and other scientific purposes without 
restriction. While recognizing national sovereignty, the Undertaking is based on the principle that plant 
genetic resources form part of the heritage of humankind and, therefore, should be conserved for future 
generations. 
Subsequent resolutions (FAO Resolutions 4/89 and 5/89) recognized that Plant Breeders’ Rights 
are not incompatible with the Undertaking and that developing countries, through the concept of Farmers’ 
Rights should be collectively compensated for their contributions to the enhancement of plant genetic 
resources. The term “Farmers’ Rights”, is defined in the text of the International Undertaking as “rights 
arising from the past, present and future contributions of farmers in conserving, improving and making 
available plant genetic resources, particularly those in the centres of origin/diversity. These rights are 
vested in the international Community, as trustee for present and future generations of farmers, and 
supporting the continuation of their contributions, as well as the attainment of the overall purpose of the 
International Undertaking. ” The CGIAR subscribes to these principles. 
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Index B 
Types of Intellectual Property 
Plant Varietv Protection or Plant Breeders’ Rights This is a national protection’ usually governed by the 
UPOV Convention, designed to give a breeder limited rights on marketable plant varieties. It generally 
gives the breeder a monopoly on the right to market the seed. Under the provisions of a new revised 
UPOV convention of 1991 this monopoly will last a minimum of 20 years for most plants and 25 years 
for trees and vines. A variety must be distinct, uniform, and stable to be protectable. Depending on the 
version of the Convention chosen and its national implementation, a farmer may be permitted to carryover 
a harvested crop to reuse for seed. Moreover, a breeder may use a protected variety for breeding 
purposes, but’ again depending on the particular version of the Convention, it may require the permission 
of the variety holder to market any modified form that has been changed so little as to constitute “an 
essentially derived variety”. This type of protection is appropriate for finished varieties. Plant breeders’ 
rights differs significantly from patents in that there is only a product (but not a process) protection. 
Patent Protection is the regular patent system, designed to protect inventions of broad applicability. It 
is also national, except in Europe, where there is a Europe-wide patent system. It gives a monopoly on 
the right to make, use or sell the invention, in return for disclosure of the invention. The monopoly is 
typically for 17 to 20 years. Normally, publication will prevent patenting. There is no equivalent to the 
farmer’s privilege. In most jurisdictions there is a research exemption which allows experimentation with 
a patented invention for non-commercial purposes. Whether the product of the research infringes the 
original patent depends on the claims of that patent. 
An invention has to meet a number of legal prerequisites for the grant of a patent. It must be: 
new; non-obvious (involve an inventive step); described adequately for another to practice the invention, 
and industrially applicable. The scope of protection is decided by the patent claims. These are carefully 
scrutinized in the examination process to ensure that the legal requirements are met for each of them. 
Copyripht is the protection appropriate to printed and literary works, and gives a monopoly on 
the right to make direct copies of protected material. The period of protection is much longer than for 
plant variety protection or patents. Certain limited copying is allowed for personal purposes. For the 
Centres, this type of protection is appropriate for publications and, under the laws of many nations, for 
computer programmes. 
Trade Secret Protection is the protection derived from actual secrecy of information, which may 
be protected against theft and, by contract, against appropriation by employees or research partners. 
There are no formal statutory requirements and there is no time limit on protection; a secrecy agreement 
does not afford protection against independent discovery by another person. It is this form of protection 
that some companies use for the information contained, for example, in a detailed genetic map. 
Material Transfer Agreements are contracts between the supplier and the recipient of material such as 
genetic material. They may include provisions governing such issues as the right of the recipient to 
retransfer the material, obligations to return the material, or rights in commercial profits that may accrue 
from the material. They may be reached in connection with each transfer or there may be agreements 
governing a number of transfers. 
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Index C 
EX SITU CONSERVATION 
All genebanks have to principal functions: the long-term preservation of plant genetic resources and the 
promotion of their use. In order to combine these two functions, two types of collections are 
internationally recognized which are defined as follows:- 
Base colIections contain distinct accessions under long-term, safe storage conditions, welldocumented, 
monitored and managed. Accessions are removed from the base collection only for infrequent 
regeneration when seed viability has declined below an acceptable standard, or when stocks of an 
accession are no longer available from an active collection. 
Currently, base collections are maintained only for orthodox seeds, e.g. seeds which can be dried and 
stored at low temperature without damaging their viability. they are dried, sealed in airtight containers 
and stored at a low temperature (usually -1” to -20”). Base collections for the storage, in vitro, of 
vegetative tissues and recalcitrant seed embryos are currently in the research stage. 
Active collections comprise accessions used for regeneration, multiplication, distribution, characterization, 
evaluation, documentation and medium-term storage. Currently, orthodox seed is maintained in active 
collections and stored at temperatures above 0” C but below 15” C. 
Particular species that are difficult to maintain as stored seed are sometimes grown, ex situ, under field 
conditions or in nurseries. Such collections are called “field genebanks” and, in general, fall within the 
category of active collections. For some species, accessions maintained in vitro are approaching routine 
use as active collections but, for others, such developments are stiI1 at the research stage. 
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Working collections (also referred to as breeders’ collections or research collections) contain material 
used for specific purposes. Storage of material in these collections is usually under ambient conditions 
or in air-conditioned rooms. The collections are regarded as outside the framework of genetic resources 
conservation, but a substantial part of them is made available through active collections. 
The accessions in the base and active collections are normally identified in published catalogues which 
define the passport information specifying the origin of the material and biological and agronomic 
characteristics of interest to the user. 
14 
Index D 
IN SITU CONSERVATION 
The purpose of in situ conservation is to ensure the survival of material in its natural environment, be 
it through nature reserves, specific scientific reserves, national parks, farmers’ fields (on-farm 
conservation) or protected areas. The conservation of germplasm in farmers’ fields is also included in 
this category since it refers to the conservation of landraces and local varieties in their agro-ecosystem. 
The CGIAR recognizes the value of this method of conservation and regards in situ and ex situ 
conservation as two complementary methods. In situ conservation is of particular importance for 
perennial species and other species that are wild or not far removed from the wild, such as many forage 
species. In situ conservation of landraces is one of many defenses against genetic erosion as a 
consequence of the introduction of modem cultivars in a particular region. The CGIAR Centres can play 
an important role in providing seeds of landraces for in situ conservation by local communities. 
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